Suppr超能文献

对Mls-1(Mtv-7 sag)的主要体内免疫反应。注射途径决定免疫反应模式。

The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern.

作者信息

Andersson M, Acha-Orbea H

机构信息

Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.

出版信息

Immunology. 1994 Nov;83(3):438-43.

Abstract

Injection of cells expressing the retroviral superantigen Mls-1 (Mtv-7 sag) into adult Mls-1- mice induces a strong immune response including both T- and B-cell activation. This model was used for studying qualitative aspects of the immune response in normal mice with a defined antigen-presenting cell (the B cell) and without the use of adjuvant. BALB/c mice were injected locally or systemically with Mls-1-expressing spleen cells from Mls-1-congenic BALB.D2 mice. Intravenous injection led to an initially strong expansion of Mls-1-reactive V beta 6+ CD4+ cells mainly in the spleen, to a large degree explained by the trapping of reactive cells, and a rapid down-regulation of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) production, consistent with the proposed tolerogenic property of B cells as antigen-presenting cells. However, these mice developed a slowly appearing but persistent B-cell response dominated by IgG1-producing cells, suggesting a shift in lymphokines produced rather than complete unresponsiveness. Subcutaneous injection into the hind footpad with the same number of cells led to a strong local response in the draining lymph node, characterized by a dramatic increase of V beta 6+ CD4+ T cells, local production of IL-2 and IFN-gamma and a strong but short-lived antibody response dominated by IgG2a-producing cells, characteristic of a T-helper type 1 (Th1) type of response. Both routes of injection led ultimately to deletion of reactive T cells and anergy, as defined by the inability to produce IL-2 upon in vitro stimulation with Mls-1. It is concluded that Mls-1 presented by B cells induces qualitatively different responses in vivo dependent on the route of injection. We propose that the different responses result from the migration of the injected cells to different micro-anatomical sites in the lymphoid tissue. Furthermore, these results suggest that B cells may function as professional antigen-presenting cells in vivo present in an appropriate environment.

摘要

将表达逆转录病毒超抗原Mls-1(Mtv-7 sag)的细胞注射到成年Mls-1-小鼠体内可诱导强烈的免疫反应,包括T细胞和B细胞的激活。该模型用于研究正常小鼠中具有明确抗原呈递细胞(B细胞)且不使用佐剂情况下免疫反应的定性方面。将来自Mls-1同基因BALB.D2小鼠的表达Mls-1的脾细胞局部或全身注射到BALB/c小鼠体内。静脉注射导致主要在脾脏中Mls-1反应性Vβ6 + CD4 +细胞最初强烈扩增,这在很大程度上是由于反应性细胞的滞留所致,并且白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)产生迅速下调,这与B细胞作为抗原呈递细胞所具有的拟耐受原性特性一致。然而,这些小鼠出现了缓慢但持续的B细胞反应,以产生IgG1的细胞为主,这表明产生的淋巴因子发生了转变,而非完全无反应。将相同数量的细胞皮下注射到后足垫导致引流淋巴结中出现强烈的局部反应,其特征为Vβ6 + CD4 + T细胞急剧增加、局部产生IL-2和IFN-γ以及以产生IgG2a的细胞为主的强烈但短暂的抗体反应,这是1型辅助性T细胞(Th1)反应的特征。两种注射途径最终都导致反应性T细胞的缺失和无反应性,这是通过在体外用Mls-1刺激时无法产生IL-2来定义的。得出的结论是,B细胞呈递的Mls-1在体内根据注射途径诱导出性质不同的反应。我们提出,不同的反应是由于注射的细胞迁移到淋巴组织中不同的微观解剖部位所致。此外,这些结果表明,B细胞在体内处于适当环境时可能作为专职抗原呈递细胞发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/1415040/fe1ba973e03d/immunology00077-0114-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验